- Previous Close
1,245.00 - Open
1,255.00 - Bid 1,282.00 x --
- Ask 1,297.00 x --
- Day's Range
1,255.00 - 1,295.00 - 52 Week Range
1,012.00 - 1,595.00 - Volume
21,000 - Avg. Volume
46,708 - Market Cap (intraday)
36.938B - Beta (5Y Monthly) --
- PE Ratio (TTM)
18.62 - EPS (TTM)
69.38 - Earnings Date May 15, 2025
- Forward Dividend & Yield 104.00 (8.05%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
--
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic coils; and insulin pumps, as well as continuous glucose monitoring, and computed tomography equipment. WIN-Partners Co., Ltd. was founded in 1973 and is headquartered in Tokyo, Japan.
www.win-partners.co.jpRecent News: 3183.T
View MorePerformance Overview: 3183.T
Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 3183.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 3183.T
View MoreValuation Measures
Market Cap
36.94B
Enterprise Value
21.09B
Trailing P/E
18.64
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.46
Price/Book (mrq)
1.62
Enterprise Value/Revenue
0.26
Enterprise Value/EBITDA
6.73
Financial Highlights
Profitability and Income Statement
Profit Margin
2.48%
Return on Assets (ttm)
4.11%
Return on Equity (ttm)
8.82%
Revenue (ttm)
82.61B
Net Income Avi to Common (ttm)
2.05B
Diluted EPS (ttm)
69.38
Balance Sheet and Cash Flow
Total Cash (mrq)
15.54B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--